While low cost cards may help alleviate the stress of large drug prices while in the short term, they do not tackle the systemic troubles driving up prescription charges in the U.S. Broader policy improvements could tackle the foundation causes of soaring drug prices, which include deficiency of transparency in pricing plus the part of intermediari